Qiong‐Yu Mi
- Cancer Research top 10%
- Immunology top 10%
- Immune Cell Function and Interaction 4
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 4
- Berberine and alkaloids research 3
-
- Drug Transport and Resistance Mechanisms 4
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 4
- Berberine and alkaloids research 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 17
-
- Platelet Disorders and Treatments 5
-
- Diabetes Treatment and Management 5
-
- Autophagy in Disease and Therapy 4
Qiong‐Yu Mi
31 papers receiving 935 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 183
- Immunology 254
- Pharmacology 81
- Oncology 226
- Pharmacology 115
Countries citing papers authored by Qiong‐Yu Mi
This map shows the geographic impact of Qiong‐Yu Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiong‐Yu Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiong‐Yu Mi more than expected).
Fields of papers citing papers by Qiong‐Yu Mi
This network shows the impact of papers produced by Qiong‐Yu Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiong‐Yu Mi. The network helps show where Qiong‐Yu Mi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiong‐Yu Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 16 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 117 | |
| 9 | 2020 | 9 | |
| 10 | 2019 | 11 | |
| 11 | 2019 | 3 | |
| 12 | 2018 | 101 | |
| 13 | 2015 | 6 | |
| 14 | 2014 | 108 | |
| 15 | 2012 | 41 | |
| 16 | 2011 | 16 | |
| 17 | 2011 | 25 | |
| 18 | 2010 | 5 | |
| 19 | 2009 | 5 | |
| 20 | 2007 | 13 |
About Qiong‐Yu Mi
Qiong‐Yu Mi is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Hematology, having authored 31 papers that have together received 937 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Platelet Disorders and Treatments (5 papers), Diabetes Treatment and Management (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Immune Cell Function and Interaction (4 papers), Autophagy in Disease and Therapy (4 papers), Inflammatory mediators and NSAID effects (4 papers) and Berberine and alkaloids research (3 papers). The work is most often cited by research in Cancer Research (183 citations), Immunology (254 citations) and Pharmacology (81 citations). Qiong‐Yu Mi has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Shuli Zhao, Jianjun Zou, Xiuting Liu, Yubing Zhu, Qianming Du, Bangshun He, Hong‐Guang Xie, Yunzhong Nie, Jianing Wang and Zhaoying Yao. Their work appears in journals such as Cell Death and Differentiation, British Journal of Pharmacology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.